DrugDev, a health technology company, is putting out a call to SaaS developers in the Boston area to join the team behind a cloud-based software platform that enables clinical trial sponsors, CROs and sites to do more clinical trials together.
The global clinical trial technology company has centralized development of its SaaS solutions in its Boston office due to the area’s combination of development talent, biopharmaceutical focus and entrepreneurial spirit.
DrugDev currently is offering $1,500 (for personal use or for a favorite charity) for any referral that leads to a successful new hire managed from the Boston area office in Newton, Mass.
“Our goal is to make DrugDev the first name people think of when they hear about pharmaceutical technology,” said Chief Technology Officer of DrugDev TrialNetworks Ezra Freedman. “We offer excellent mentorship and career advancement opportunities, a collaborative and friendly culture, opportunities to work with leading Web-based platforms and contribute to open-source architecture—as well as a fairly competitive pingpong scene.”
Freedman co-founded TrialNetworks (acquired by DrugDev in 2014) with Eric Silberstein and their colleague Dr. Vivek Murthy, who now is U.S. surgeon general.
Demand for DrugDev solutions is increasing, spurred by client adoption of new solutions as well as major industry initiatives including the TransCelerate Investigator Registry (launching this year). The Boston office in particular has doubled its office space twice and tripled its development team during the past 18 months, with continued expansion planned.